本次大会还展示了除利伐沙班和达比加群外的其他有效药物。
The congress showed that there are also other drugs besides rivaroxiban and dabigatran that are effective.
结论：利伐沙班对预防下肢深静脉血栓形成可获得良好的效果。
Conclusion: there is a good effect of the Rivaroxaban to take precautions against formation of the Phlebothrombosis.
利伐沙班增加了严重出血和颅内出血的危险，但不增加致死性出血的危险。
Rivaroxaban increased the risk of major bleeding and intracranial hemorrhage but not the risk of fatal bleeding.
结论在近期有过一次急性冠脉综合征的患者中，利伐沙班降低了包括心血管原因所致死亡、心肌梗死或卒中的复合终点的发生危险。
CONCLUSIONS in patients with a recent acute coronary syndrome, rivaroxaban reduced the risk of the composite end point of death from cardiovascular causes, myocardial infarction, or stroke.
结论在近期有过一次急性冠脉综合征的患者中，利伐沙班降低了包括心血管原因所致死亡、心肌梗死或卒中的复合终点的发生危险。
CONCLUSIONS in patients with a recent acute coronary syndrome, rivaroxaban reduced the risk of the composite end point of death from cardiovascular causes, myocardial infarction, or stroke.
应用推荐